Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Bogéa, Gabriela Muller Reche | - |
Autor(es): dc.creator | Carvalho, Amandda Évelin Silva de | - |
Autor(es): dc.creator | Braga, Luma Dayane de Carvalho Filiú | - |
Autor(es): dc.creator | Neves, Francisco de Assis Rocha | - |
Autor(es): dc.creator | Araujo, Felipe Saldanha de | - |
Data de aceite: dc.date.accessioned | 2024-07-22T11:45:33Z | - |
Data de disponibilização: dc.date.available | 2024-07-22T11:45:33Z | - |
Data de envio: dc.date.issued | 2022-05-09 | - |
Data de envio: dc.date.issued | 2022-05-09 | - |
Data de envio: dc.date.issued | 2021 | - |
Fonte completa do material: dc.identifier | https://repositorio.unb.br/handle/10482/43672 | - |
Fonte completa do material: dc.identifier | https://doi.org/10.3389/fonc.2022.858425 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/788023 | - |
Descrição: dc.description | The development of immunotherapeutic approaches for the treatment of melanoma requires a better understanding of immunoescape mechanisms of tumor cells and how they interact with other tumor-resident cell types. Here, we evaluated how the conditioned media of resting (rCM) and immune-activated PBMCs (iCM) influence the ability of a metastatic melanoma cell line (MeWo) to control T-cells function. MeWo cells were expanded in RPMI, rCM, or iCM and the secretome generated after cell expansion was identified as MeSec (RPMI), niSec (non-inflammatory), or iSec (inflammatory secretome), respectively. Then, the immunomodulatory potential of such secretomes was tested in PHA-activated PBMCs. iCM induced higher levels of IFN-γ and IL-10 in treated melanoma cells compared to rCM, as well as higher IDO and PD-L1 expression. The iSec was able to inhibit T-cell activation and proliferation. Interestingly, PBMCs treated with iSec presented a reduced expression of the regulators of Th1 and Th2 responses T-BET and GATA-3, as well as low expression of IFN-γ, and co-stimulatory molecules TIM-3 and LAG-3. Importantly, our findings show that melanoma may benefit from an inflammatory microenvironment to enhance its ability to control the T-cell response. Interestingly, such an immunomodulatory effect involves the inhibition of the checkpoint molecules LAG-3 and TIM-3, which are currently investigated as important therapeutic targets for melanoma treatment. Further studies are needed to better understand how checkpoint molecules are modulated by paracrine and cell contact-dependent interaction between melanoma and immune cells. Such advances are fundamental for the development of new therapeutic approaches focused on melanoma immunotherapy. | - |
Formato: dc.format | application/pdf | - |
Publicador: dc.publisher | Frontiers | - |
Direitos: dc.rights | Acesso Aberto | - |
Direitos: dc.rights | (CC BY) | - |
Palavras-chave: dc.subject | Melanoma | - |
Palavras-chave: dc.subject | Células T | - |
Palavras-chave: dc.subject | Resposta imunológica | - |
Palavras-chave: dc.subject | Secretoma | - |
Título: dc.title | The inflammatory status of soluble microenvironment influences the capacity of melanoma cells to control t-cell responses | - |
Aparece nas coleções: | Repositório Institucional – UNB |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: